Purdue David Ryan
SVP, Controller
Purdue David Ryan has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Mar 11, 2026.
On the most recent filing, Purdue David Ryan is listed as SVP, Controller at AbbVie Inc. Inside the rolling window, Purdue David Ryan reported no open-market purchases and 1 open-market sale totaling $1.2M in ABBV.
Companies traded
Other insiders at ABBV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Purdue David Ryan made?
Purdue David Ryan has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Purdue David Ryan trade?
Purdue David Ryan has filed SEC Form 4 disclosures for 1 company, including ABBV.
When was Purdue David Ryan's most recent SEC Form 4 filing?
Purdue David Ryan's most recent SEC Form 4 filing on Tracefour is dated Mar 11, 2026.
What is Purdue David Ryan's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Purdue David Ryan is listed as SVP, Controller.
What is Purdue David Ryan's total buy and sell value in the current window?
Inside the rolling retention window, Purdue David Ryan bought $0 and sold $1.2M based on SEC Form 4 filings.
What was Purdue David Ryan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,230 ABBV shares on 2026-03-04, worth $1.2M, per SEC Form 4 filings.